About Glycerol kinase
Glycerol kinase (GK) is a protein
from Homo sapiens identified by UniProt accession
P32189, 559 residues long.
MolForge cross-references it against 0 known binders and
182 disease associations.
Target properties
| Protein name | Glycerol kinase |
| UniProt accession | P32189 |
| Gene | GK |
| Organism | Homo sapiens |
| Length | 559 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (182)
Diseases linked to this target (Open Targets).
- inborn glycerol kinase deficiency · score 0.71
- Glycerol kinase deficiency · score 0.64
- isolated glycerol kinase deficiency · score 0.52
- glycerol kinase deficiency, juvenile form · score 0.37
- glycerol kinase deficiency, adult form · score 0.37
- genetic disorder · score 0.33
- Global developmental delay · score 0.12
- Absent speech · score 0.12
- Seizure · score 0.12
- azoospermia · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P32189-F1 | alphafold | PREDICTED | 91.65 | — |
Amino-acid sequence (559 residues)
MAASKKAVLG PLVGAVDQGT SSTRFLVFNS KTAELLSHHQ VEIKQEFPRE GWVEQDPKEI LHSVYECIEK TCEKLGQLNI DISNIKAIGV SNQRETTVVW DKITGEPLYN AVVWLDLRTQ STVESLSKRI PGNNNFVKSK TGLPLSTYFS AVKLRWLLDN VRKVQKAVEE KRALFGTIDS WLIWSLTGGV NGGVHCTDVT NASRTMLFNI HSLEWDKQLC EFFGIPMEIL PNVRSSSEIY GLMKISHSVK AGALEGVPIS GCLGDQSAAL VGQMCFQIGQ AKNTYGTGCF LLCNTGHKCV FSDHGLLTTV AYKLGRDKPV YYALEGSVAI AGAVIRWLRD NLGIIKTSEE IEKLAKEVGT SYGCYFVPAF SGLYAPYWEP SARGIICGLT QFTNKCHIAF AALEAVCFQT REILDAMNRD CGIPLSHLQV DGGMTSNKIL MQLQADILYI PVVKPSMPET TALGAAMAAG AAEGVGVWSL EPEDLSAVTM ERFEPQINAE ESEIRYSTWK KAVMKSMGWV TTQSPESGDP SIFCSLPLGF FIVSSMVMLI GARYISGIP
Explore Glycerol kinase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets